Ferric Derisomaltose and Tranexamic Acid, Combined or Alone, for Reducing Blood Transfusion in Patients with Hip Fracture (the HiFIT Trial): A Multicentre, 2 × 2 Factorial, Randomised, Double-Blind, Controlled Trial.|Citation only
Ferric Derisomaltose and Tranexamic Acid, Combined or Alone, for Reducing Blood Transfusion in Patients with Hip Fracture (the HiFIT Trial): A Multicentre, 2 × 2 Factorial, Randomised, Double-Blind, Controlled Trial.|Citation only